News

It is not unusual for people living with osteoarthritis to experience pain so severe it makes daily tasks almost impossible. In a recent survey of 600 patients scheduled to undergo knee or hip replacement surgery, about 20 per cent said they had turned to cannabis products to help them manage...

Arthritis Society marking Arthritis Awareness Month with campaign to support the six million Canadians with the diseaseSix million Canadians have arthritis, but those who live with the diagnosis say its impact on their lives is too often diminished. More than 79 per cent of respondents in a...

The Arthritis Society is deeply saddened about the passing on July 24, 2020 of its Past Board Chair, Kenneth Smith.“Ken was a passionate advocate for people with arthritis and he made a huge contribution towards lessening the impact of the disease on millions of Canadians,” says Trish...

Annie Lévesque cannot keep quiet any longer. She has joined voices with the 4, 000 Canadians who have called on the provincial and federal governments to find solutions to joint replacement delays affecting osteoarthritis patients. In March 2020, at the very beginning of the pandemic, Annie’s...

Arthritis Society president and CEO Trish Barbato talks with the Discovery Pod about joining the organization just before the COVID-19 pandemic, the challenges facing charities in the face of a global shutdown, and how innovation will play a key role as the organization evolves to meet the...

Dr. Arif Jetha from the Institute of Work and Health examines the impact of COVID-19 on workers with hidden health conditions. Our chief science officer, Dr. Sian Bevan, comments on the concerns expressed by people with arthritis. Dr. Jetha's work is partly funded by an Arthritis Society...

In this powerful perspective piece, Mari "Dev" Ramsawakh, who lives with a chronic pain and fatigue from a disability, writes about how COVID-19 has suddenly made accessibility everybody's priority. People with arthritis can identify.  

Chloroquine and hydroxychloroquine supplies are low due to coronavirus, causing concern for patients who rely on the drugs to treat conditions like lupus and rheumatoid arthritis. The Arthritis Society is working with governments to limit the extent to which arthritis patient care impacted by...

Our Chief Science Officer, Dr. Sian Bevan, and arthritis ambassador Darlene McPherson, comment on how COVID-19 has led to a shortage of Hydroxychloroquine – a drug used to treat Rheumatoid Arthritis and Lupus – and how it's impacting patients. The Arthritis Society continues to...